Biotech Disruption
In my latest Business Week column I make the case that the biotech industry has morphed into Big Pharma. We need to realize the disruptive potential of biotechnology for personalized medicine if we are going to transform our U.S. health care system.
The national health-care debate is many things to many business interests. To the biotech industry, it seems to be a matter of life and death. Makers of biotech drugs, which are derived by manipulating genetic material in living organisms, insist that their products must be patent-protected from generic “biosimilars” for at least 12 years. That would ensure monopoly prices, which the industry says are required to earn back their big investments in research and development.
To reform the U.S. health-care system, the government shouldn’t be creating a road map to biosimilars, however long the trip. Instead, it should open the floodgate to “biodissimilars” and to the personalized medicine options they will enable.
Continue reading Business Week column here.
While I can “see” what you are presenting to your audience,Health Care itself is so complex,Bio-tech aspect is a new concept compared to “patient care oriented” care.In fact, this approach has been left in the dust as patients are now “clients” and the interdisciplinary-co-operative approach to patient care has turned into an adversarial relationship.The legal profession,aided by survivors playing the “blame game” contributes to this problem.We are, quite simply,practicing defensive medicine and nursing,as our Malpractice insurance premiums have skyrocketed~because of public perceptions and expectations.Medicine,with all our innovations, is still an inexact,overburdened science.The red-tape, government system has replaced our vocations with paper-shuffling and documentation.When you wish to learn the truth,please feel free to contact me and my husband.We have retired from the Medical field we feel we were given the gift to serve because of unrealistic expectations and angry people.Thank you.MaryLynn Neill
[...] This post was mentioned on Twitter by Saul Kaplan, Getting2 IHM. Getting2 IHM said: RT @skap5 Calling for Biotech to live up to its potential as a disruptive force for personalized medicine. #TedMED http://bit.ly/1hdrgc [...]